S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.79%) $83.19
Gas
(-1.16%) $1.619
Gold
(-0.05%) $2 346.10
Silver
(-0.22%) $27.48
Platinum
(0.24%) $924.30
USD/EUR
(-0.10%) $0.934
USD/NOK
(-0.05%) $11.02
USD/GBP
(-0.16%) $0.799
USD/RUB
(0.00%) $92.17

リアルタイムの更新: Nuwellis, Inc. [NUWE]

取引所: NASDAQ セクター: Healthcare 産業: Medical Devices
最終更新日時27 4月 2024 @ 05:00

-41.94% US12542Q70 0.168

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):
Profile picture for Nuwellis, Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics...

Stats
本日の出来高 18.26M
平均出来高 1.27M
時価総額 1.14M
EPS US12542Q700 ( 2024-03-05 )
次の収益日 ( US12542Q70-0.930 ) 2024-05-14
Last Dividend US12542Q700 ( N/A )
Next Dividend US12542Q700 ( N/A )
P/E -0.0100
ATR14 US12542Q700.00100 (0.59%)
Insider Trading
Date Person Action Amount type
2024-01-02 Mccormick Michael Kendrick Buy 20 836 Nonstatutory Stock Option (right to buy)
2024-01-02 Mcdonald David Buy 11 365 Nonstatutory Stock Option (right to buy)
2024-01-02 Feldshon Archelle Georgiou Buy 11 365 Nonstatutory Stock Option (right to buy)
2023-11-01 Mcdonald David Buy 0
2023-11-01 Feldshon Archelle Georgiou Buy 0
INSIDER POWER
97.91
Last 90 transactions
Buy: 3 285 386 | Sell: 12 287

ボリューム 相関

長: -0.21 (neutral)
短: -0.23 (neutral)
Signal:(56.294) Neutral

Nuwellis, Inc. 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Nuwellis, Inc. 相関 - 通貨/商品

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.03
( neutral )

Nuwellis, Inc. 財務諸表

Annual 2023
収益: US12542Q708.86M
総利益: US12542Q704.98M (56.22 %)
EPS: US12542Q70-10.29
FY 2023
収益: US12542Q708.86M
総利益: US12542Q704.98M (56.22 %)
EPS: US12542Q70-10.29
FY 2022
収益: US12542Q708.54M
総利益: US12542Q704.76M (55.66 %)
EPS: US12542Q70-83.48
FY 2021
収益: US12542Q707.92M
総利益: US12542Q704.49M (56.70 %)
EPS: US12542Q70-285.73

Financial Reports:

No articles found.

Nuwellis, Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。